# Celebrity-backed cancer treatment venture eyes London listing

- URL: https://talkfuse.com/story/celebrity-backed-cancer-treatment-venture-eyes-london-listing/
- Published: 2026-11-16T10:03:27+00:00
- Updated: 2026-11-16T10:19:52+00:00
- Original publisher: City AM (publisher lean: Right)
- Original article: https://www.cityam.com/celebrity-backed-cancer-treatment-venture-eyes-london-listing/
- Topics: Business, Celebrity, Companies, Entertainment, Health, Markets, Medicine, UK, World

## Key points

- Ellipses Pharma is targeting a London listing through a reverse takeover.
- The deal could value the cancer drug venture at £450m to £500m.
- Abu Dhabi’s Mubadala fund holds a 45 per cent stake.

## Summary

Ellipses Pharma, a clinical-stage cancer drug venture founded by British biotech entrepreneur Sir Chris Evans, is preparing to list in London through a reverse takeover. The proposed deal could value the company at £450m to £500m and would be a boost for a London market facing a decline in new listings, including in biotech and pharmaceuticals.

The company’s investors include Evans, Jimmy Carr, Andrew Lloyd Webber, Steve Morgan and Sir Tom Hunter’s West Coast Capital; Abu Dhabi’s Mubadala sovereign wealth fund is its largest investor, with a 45 per cent stake. Ellipses employs around 40 people and has invested about £185m in its drug pipeline. It is targeting a listing as soon as February by merging with cash shell Wolfram Resources, with advisers reportedly appointed and a formal announcement possible this week.

---
Summarised by TalkFuse (https://talkfuse.com/). Quote the original publisher for the reporting and link this page for the summary and discussion.
